Health eHeart BioBank

Enrolling by invitationOBSERVATIONAL
Enrollment

500,000

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

December 31, 2035

Study Completion Date

December 31, 2035

Conditions
Heart DiseasesCardiac DiseasesVascular DiseasesCardiovascular Diseases
Interventions
PROCEDURE

Blood Draw

Participants will be asked to contribute approximately 36 mL of blood using standard procedures and obtained at the time of a clinically ordered routine blood draw or a study ordered blood draw. Participants may be asked to contribute additional blood samples over the course of their participation in the study.

PROCEDURE

Tissue Collection

If the participant is undergoing a clinically ordered procedure (e.g. heart surgery/biopsy/transplant), then they will be asked to contribute tissue to the study before any tissue is collected during the procedure. Most samples collected by the HeH BioBank will be tissue that would be normally discarded after the procedure.

PROCEDURE

DNA Collection

Participants will be asked to contribute their DNA for Whole Genome Sequencing (WGS) to help identify genetic markers of heart disease. DNA will be obtained at the time of the blood draw or obtained through DNA collection kits administered to participants who are unable or unwilling to undergo a blood draw.

OTHER

Medical Chart Review

Demographic, clinical, and pathologic information will be extracted from the participant's medical record.

Trial Locations (1)

94158

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER